Bibliography
- Kantor AB , DengJ, WaubantJEet al. : Identification of short-term pharmacodynamic effects of interferon-β-1a in multiple sclerosis subjects with broad-based phenotypic profiling.J. Neuroimmunol.188, 103–116(2007).
- Bennett EJ , ShalerTA, Woodman,Bet al. : Global impairment of the ubiquitin system in Huntington‘s Disease.Nature448, 704–709(2007).
- Roy S , JosephsonA, FridlyandJet al. : Protein biomarker identification in the cerebrospinal fluid in patients with central nervous system lymphoma.J. Clin. Oncol.26, 96–105(2008).
- Wagner JA : Strategic approach to fit-for-purpose biomarkers in drug development.Annu. Rev. Pharmacol. Toxicol.48, 631–651(2008).
- Wang W , ZhouH, LinHet al. : Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards.Anal. Chem.75, 4818–4826(2003).
- The Association of Biomolecular Resource Facilities. www.abrf.org/index.cfm/group.show/Proteomics.34.htm